Latarjet vs. Modified Eden-Hybinette for Recurrent Anterior Shoulder Dislocation
This study compares the effectiveness of Latarjet and Modified Eden-Hybinette procedures in improving shoulder stability, as measured by the Western Ontario Shoulder Instability Index (WOSI), in individuals with recurrent anterior shoulder dislocation.
Latarjet procedure
+ Modified Eden-Hybinette
Shoulder Injuries+3
+ Joint Dislocations
+ Joint Diseases
Treatment Study
Summary
Study start date: September 1, 2016
Actual date on which the first participant was enrolled.This study focuses on finding the best treatment for recurrent anterior dislocation of the shoulder, a condition where the shoulder frequently slips out of its socket. It compares two surgical techniques: Latarjet and Modified Eden-Hybinette. The Latarjet technique has shown reliable results with low recurrence rates, but it comes with potential complications like neurological injuries and graft resorption. On the other hand, the Eden-Hybinette surgery has fewer risks and allows better restoration of the shoulder area, but it lacks the benefits of the 'sling effect' provided by the Latarjet technique. This research aims to address the current lack of high-quality studies comparing these two techniques, hoping to improve care and treatment outcomes for individuals with this condition. During the study, participants will undergo either the Latarjet or the Modified Eden-Hybinette surgery. The effectiveness of these surgeries will be measured using the Western Ontario Shoulder Instability Index (WOSI), a standard tool for assessing shoulder instability. This will help evaluate the success of each technique in reducing shoulder dislocations and improving overall shoulder function.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.60 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 16 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Active ComparatorGroup II
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Instituto de Ortopedia e Traumatologia
São Paulo, BrazilOpen Instituto de Ortopedia e Traumatologia in Google Maps